While other MediaPost newsletters and articles remain free to all ... our new Research Intelligencer service is reserved for paid subscribers ...
Subscribe today to gain access to every Research Intelligencer article we publish as well as the exclusive daily newsletter, full access to The MediaPost Cases, first-look research and daily insights from Joe Mandese, Editor in Chief.
Become a free MediaPost member now to read this article
Unlimited articles every day
Keep up-to-date with media, marketing and advertising news
Invitations to exclusive industry events and research
Subscribe to MediaPost Agency Daily
None
by
August 4, 2003
Pfizer is taking away its anti-arthritis drug Celebrex from J. Walter Thompson, New York. Kaplan Thaler Group, New York, and Arnold Worldwide, Boston, will now compete for the account.
